Timo Rieg

84 papers receiving 5.2k citations

Timo Rieg's Hit Papers

SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice 2013 · 408 citations
4080+5+10Years since publication100200300400

Peers

Timo Rieg
Comparison fields: 5 of 121
  • Nephrology 1.0k
  • Endocrinology, Diabetes and Metabolism 1.9k
  • Physiology 385
  • Clinical Biochemistry 211
  • Molecular Biology 2.2k
Replace Scott C. Thomson with:
Scott C. Thomson United States
Takashi Uzu Japan
Helmy M. Siragy United States
Shin‐ichi Araki Japan
Hiroyuki Kobori United States
Atsuhiro Ichihara Japan
Duncan J. Campbell Australia
Youichi Abe Japan
Raymond Ardaillou France
Atsunori Kashiwagi Japan
Timo Rieg relative to Scott C. Thomson United States Scott C. Thomson's profile →
Citations per field
00.5×1.6×
Scott C. Thomson · 1×
Citations per year

Countries citing papers authored by Timo Rieg

Since Specialization
Citations

This map shows the geographic impact of Timo Rieg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Rieg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Rieg more than expected).

Fields of papers citing papers by Timo Rieg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timo Rieg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Rieg. The network helps show where Timo Rieg may publish in the future.

Co-authors

The 25 scholars most cited alongside Timo Rieg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Timo Rieg Line = papers co-authored together Timo Rieg links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.

#Work
1
SGLT2 Mediates Glucose Reabsorption in the Early Proximal Tubule
Hit paper breakdown →
2010455
2
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
Hit paper breakdown →
2013408
3 2012331
4 2018262
5 2013250
6 2011246
7 2008203
8 2005177
9 2007157
10 2012136
11 2007134
12 2015130
13 2007124
14 2008118
15 2005110
16 2008107
17 201298
18 201086
19 201178
20 201176

About Timo Rieg

Timo Rieg is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Nephrology, Endocrinology, Diabetes and Metabolism and Surgery, having authored 88 papers that have together received 5.3k indexed citations. Recurring topics across this work include Ion Transport and Channel Regulation (39 papers), Electrolyte and hormonal disorders (22 papers), Pancreatic function and diabetes (15 papers), Diabetes Treatment and Management (13 papers), Adenosine and Purinergic Signaling (10 papers), Parathyroid Disorders and Treatments (10 papers), Chronic Kidney Disease and Diabetes (7 papers) and Hormonal Regulation and Hypertension (7 papers). The work is most often cited by research in Nephrology (1.0k citations), Endocrinology, Diabetes and Metabolism (1.9k citations), Physiology (385 citations), Clinical Biochemistry (211 citations) and Molecular Biology (2.2k citations). Timo Rieg has collaborated with scholars based in United States, Denmark and Germany. Frequent co-authors include Volker Vallon, Scott C. Thomson, Hermann Koepsell, Maria Gerasimova, Kenneth A. Platt, Jessica A. Dominguez, Robert A. Fenton, Michael Rose, Joseph Satriano and Jana Schroth. Their work appears in journals such as American Journal of Physiology-Renal Physiology, The FASEB Journal, Journal of the American Society of Nephrology, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology and Kidney International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact